Actually, both IFNs have been described to contribute to the IFN signature in RA (33, 34) and the IFNβ/α ratio has been reported to be a predictor of good therapeutic response in anti-TNF-treated patients (33). This evidence concerns the gene IFNA1 and rheumatoid arthritis.